Pulmatrix share price logo

Pulmatrix

NASDAQ: PULM

$1.50

(+-0.33%)

as on

Pulmatrix Stock Performance

as on August 22, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.49
    $1.55
    downward going graph

    0.67%

    Downside

    3.33%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.16
    $5.50
    downward going graph

    22.67%

    Downside

    266.53%

    Upside

    downward going graph

Pulmatrix share price movements today

Previous Close
$1.50
Open
$1.50
Volume
167.9K
Market Cap
$5.6M
Day's Low - High
$1.49 - $1.55
52 Week Low - High
$1.16 - $5.50

Pulmatrix Historical Returns

1 Month Return
-8.88 %
3 Month Return
+ 23.2 %
1 Year Return
-67.3 %
3 Year Return
-38.28 %
5 Year Return
-89.84 %

Pulmatrix Stock Fundamentals & Key Indicators

Check Pulmatrix market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.6M

EPS (TTM)

-1.1

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.37

Industry PE ratio

-1.5966015625

PEG Ratio

-0.017854775675255546

EBITDA

-4.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-109.70%

Pulmatrix Stock Valuation

Track how Pulmatrix P/E has moved over time to understand its valuation trends.

Pulmatrix in the last 5 years

  • Overview

  • Trends

Lowest (-2.66x)

December 31, 2024

Industry (-1.60x)

December 31, 2025

Today (-1.58x)

December 31, 2025

Highest (-0.48x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -1.58x

Pulmatrix vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pulmatrix with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$5.6M-89.84%-1.370.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Pulmatrix Stock including INR - Dollar returns

The Pulmatrix stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Pulmatrix investment value today

Current value as on today

₹34,909

Returns

-₹65,091

(-65.09%)

Returns from Pulmatrix Stock

-₹68,153 (-68.15%)

Dollar Impact

₹3,061 (+3.06%)

Analyst Recommendation on Pulmatrix Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Pulmatrix. Average target price of $10

Pulmatrix Share Price Target

Get share price movements and forecasts by analysts on Pulmatrix.

What analysts predicted

85%UPSIDE

Target Price

$10

Current Price

$1.5

Analyzed by

7 Analysts

Target

$10.00

Pulmatrix target price $10, a slight upside of 85% compared to current price of $1.5. According to 7 analysts rating.

Indian Investors' Interest in Pulmatrix Stock

Search interest for Pulmatrix Stock has increased by 77% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:77% versus previous 30 day period

Pulmatrix Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
5
1
0
0
-
-
-
-
-
-
Gross Profit
2
-1
0
0
0
0
-
0
-
-
Operating Income
0
-5
-2
-1
-1
-1
0
0
-1
-1
EBITDA
0
-3
-2
-1
-1
-1
0
0
-1
-1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
-
-
0
0
-
-
-
-
Income Before Tax
0
-5
-2
-1
-1
-1
0
0
-1
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
-5
-2
-1
-1
-1
0
0
-1
-1
Net Profit Margin
40.32%
-82.60%
-122.40%
-100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pulmatrix Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
7
12
5
6
7
7
-
Gross Profit
-9
-12
-4
12
-10
-12
-8
0
0
Operating Income
-17
-20
-20
-9
-20
-18
-14
-9
-5
EBITDA
-17
-20
-13
-9
-16
-18
-13
-7
-5
Interest Expense
0
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
-
Income Before Tax
-18
-20
-20
-19
-20
-18
-14
-9
-5
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-18
-20
-20
-19
-20
-18
-14
-9
-5
Net Profit Margin
-2957.61%
-8374.51%
-62.39%
100.00%
-197.58%
-200.44%
-112.63%
8.20%
0.00%

Pulmatrix Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
-5
-2
-1
-1
-1
0
0
-1
-1
Operating Cash Flow
-2
-3
-3
-1
-1
-1
-1
0
-1
-1
Investing Cash Flow
0
0
-
-
-
-
-
-
-
-
Financing Cash Flow
-
-
-
-
-
-
-
-
1
0
Change in Cash
-2
-2
-3
-1
-1
-1
-1
0
0
-1

Pulmatrix Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-18
-20
-20
-19
-20
-18
-14
-9
-5
Operating Cash Flow
-14
-16
3
-12
-19
-19
-15
-10
-5
Investing Cash Flow
0
0
0
0
0
0
0
0
-
Financing Cash Flow
13
15
17
20
43
1
0
-
-
Change in Cash
0
0
20
8
23
-18
-16
-11
-5

Mutual Funds that own Pulmatrix Stock

Check out the Mutual Funds with significant holdings in Pulmatrix.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.921395%
33652
VANGUARD INDEX FUNDS
0.919807%
33594

Global Institutional Holdings in Pulmatrix

Funds
Holdings
Vanguard
0.88%

Pulmatrix News & Key Events

  • img

    Today's Timeline - 13 August

    Thu, 05:45 PM

    -

    Pulmatrix reports Q2 2026 net loss of $1.04M and files Form S-4 for Eos merger.

Insights on Pulmatrix

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.17M → -1.03M (in $), with an average increase of 13.1% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 586.8% return, outperforming this stock by 626.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 466.0% return, outperforming this stock by 535.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 5.88M → 3.0K (in $), with an average decrease of 83.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, PULM stock has moved down by -47.4%

About Pulmatrix

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing PUR1800, a narrow spectrum kinase inhibitor completed Phase 1b clinical trials for the treatment of acute exacerbations in chronic obstructive pulmonary disease; PUR1900 for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis; and PUR3100, an iSPERSE formulation of dihydroergotamine which is in Phase 1 for the treatment of acute migraine. It has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor compounds. The company was founded in 2003 and is headquartered in Framingham, Massachusetts.
OrganisationPulmatrix
Headquarters945 Concord Street, Framingham, MA, United States, 01701
IndustryBiotechnology
CEOMr. Peter Ludlum CMA, MBA
E-voting on sharesClick here to vote

Key Management of Pulmatrix

Name

Title

Mr. Peter Ludlum CMA, MBA

Interim CEO & Interim CFO

Dr. Alexander M. Klibanov Ph.D.

Founder

FAQs

What is Pulmatrix share price today?

Pulmatrix share price today is $1.50 as on at the close of the market. Pulmatrix share today touched a day high of $1.55 and a low of $1.49.

What is the 52 week high and 52 week low for Pulmatrix share?

Pulmatrix share touched a 52 week high of $5.50 on and a 52 week low of $1.16 on . Pulmatrix stock price today i.e. is closed at $1.50,which is 72.72% down from its 52 week high and 29.31% up from its 52 week low.

What is Pulmatrix's market capitalisation today?

Pulmatrix market capitalisation is $0.00T as on .

How to invest in Pulmatrix Stock (PULM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pulmatrix on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pulmatrix Shares that will get you 1.0000 shares as per Pulmatrix share price of $1.50 per share as on August 22, 2026 at 8:46 am IST.

What is the minimum amount required to buy Pulmatrix Stock (PULM) from India?

Indian investors can start investing in Pulmatrix (PULM) shares with as little as ₹95.685 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹956.85 in Pulmatrix stock (as per the Rupee-Dollar exchange rate as on ). Based on Pulmatrix share’s latest price of $1.50 as on August 22, 2026 at 8:46 am IST, you will get 6.6667 shares of Pulmatrix. Learn more about fractional shares .

What are the returns that Pulmatrix has given to Indian investors in the last 5 years?

Pulmatrix stock has given -89.84% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?